IO Biotech raises $155m to develop breakthrough cancer vaccineIO Biotech, an oncology specialist formed and backed by Denmark’s Novo Holdings, has raised €127 million ($155 million) Share XIO Biotech raises $155m to develop breakthrough cancer vaccinehttps://pharmaphorum.com/news/io-biotech-raises-155m-to-develop-breakthrough-cancer-vaccine/
